Dr. Perminder J S Bhatia, MD

Dr. Bhatia practices at Neuro-Pain Medical Center Inc in Fresno, California.

Dr. Bhatia's NPI, 1013002328, was assigned on October 3, 2006. Dr. Bhatia graduated from Government Medical College Amritsar in 1988. Dr. Bhatia holds California license A61797.

Dr. Bhatia's primary practice is Neuro-Pain Medical Center Inc, at 736 E Bullard Ave, Fresno, CA 93710 in Fresno County. The practice phone is (559) 437-9700.

Dr. Bhatia's primary practice is Neuro-Pain Medical Center Inc in Fresno, California. Dr. Bhatia is also affiliated with Community Regional Medical Center. The medical group on file is Community Regional Medical Center. Dmand AI also links Dr. Bhatia to 5 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatia practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bhatia's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bhatia is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bhatia's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Bhatia treats.

CMS data shows 5,974 Medicare services from Dr. Bhatia across 28 procedure codes in 2024, for 1,561 Medicare patients. Medicare paid $666,993 for them.

CMS counts 1,561 Medicare patients who saw Dr. Bhatia in 2024. The largest group is 75 to 84, with 591 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatia's median patient age at 71, with 60% women.

In 2024, Dr. Bhatia wrote 6,167 Medicare Part D claims for 1,020 patients. 84% of them were for generic drugs. CMS names the drug for 5,728 of them, across 90 drugs with 11 or more claims each, at $2,742,063 in total drug cost. In 2023, CMS named 5,115 claims across 92 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bhatia for performance year 2024, reported individually. Dr. Bhatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhatia as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Bhatia, published from 2015 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Anticonvulsants and Seizures. Dr. Bhatia has published most often in Epilepsia. Dr. Bhatia's most frequent co-authors are Bassel Abou-Khalil, MD, Sami Mohamad Aboumatar, MD and Victor Biton, MD.

Dmand AI links Dr. Bhatia to 19 clinical trials, 4 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Cognitive Dysfunction, Alzheimer Disease and Epilepsies, Partial. Daiichi Sankyo sponsors the most, 3. Open Payments lists research payments to Dr. Bhatia that name 10 trials.

CMS Open Payments shows 2,644 general payments to Dr. Bhatia from 104 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Mallinckrodt LLC paid the most, $40,040. It also lists 146 research payments totaling $123,140 from 2016 to 2025, naming 10 clinical trials.

Dmand AI lists 1 award for Dr. Bhatia, most recently CMS Stage 1 2012 in 2011.

Dr. Bhatia graduated from Government Medical College Amritsar in 1988. Dr. Bhatia is a member of AAN.

Dr. Bhatia is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.